Koichi Nakatani

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.

Journal: The oncologist

Published: April 08, 2022

Primary Pulmonary Malignant Melanoma Successfully Treated with Immunotherapy in a 90-Year-Old Patient.

Primary Pulmonary Malignant Melanoma Successfully Treated with Immunotherapy in a 90-Year-Old Patient.

Journal: Case reports in oncology

Published: February 28, 2022

Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.

Serial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.

Journal: Cancer immunology, immunotherapy : CII

Published: October 17, 2021

Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.

Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.

Journal: Thoracic cancer

Published: August 25, 2021

No need to hesitate: immune-related neutropenia and thrombocytopenia that improved by corticosteroids.

No need to hesitate: immune-related neutropenia and thrombocytopenia that improved by corticosteroids.

Journal: Respirology case reports

Published: April 12, 2021

Efficacy and safety of immune checkpoint inhibitors in patients with non-small cell lung cancer aged 80 years or older.

Efficacy and safety of immune checkpoint inhibitors in patients with non-small cell lung cancer aged 80 years or older.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 29, 2021

Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation.

Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation.

Journal: Respiratory medicine case reports

Published: December 22, 2020

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non-small cell lung cancer.

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 20, 2020

Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?

Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?

Journal: Respiratory medicine case reports

Published: November 10, 2020

Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma.

Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma.

Journal: Respiratory medicine case reports

Published: August 19, 2020

Impact of COVID-19 pandemic on lung cancer treatment scheduling.

Impact of COVID-19 pandemic on lung cancer treatment scheduling.

Journal: Thoracic cancer

Published: June 30, 2020

Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Journal: Open forum infectious diseases

Published: February 12, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026